Urinary biomarkers of oxidative status in a clinical model of oxidative assault

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 6, 2010, Pages 1506-1510

  Il'Yasova, Dora ^a   Spasojevic, Ivan ^a   Wang, Frances ^a   Tolun, Adviye A ^a   Base, Karel ^a   Young, Sarah P ^a   Marcom, P Kelly ^a   Marks, Jeffrey ^a   Mixon, Gabriel ^b   DiGiulio, Richard ^b   Millington, David S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ISOPROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; FREE RADICAL; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; URINALYSIS; ADOLESCENT; BREAST NEOPLASMS; MIDDLE AGED; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; ALLANTOIN; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; CYCLOPHOSPHAMIDE; DOXORUBICIN; F2-ISOPROSTANES; FEMALE; FREE RADICALS; HUMANS; MASS SPECTROMETRY; MIDDLE AGED; OXIDATIVE STRESS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77953310221     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0211     Document Type: Article

References (16)

1. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004;142:231-55.
2. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning? Free Radic Biol Med 2000;28:838-45.
3. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;56: 185-229. (Pubitemid 38720829)
4. Rajagopalan S, Politi PM, Sinha BK, Myers CE. Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res 1988;48:4766-9.
5. Il'yasova D, Mixon G, Wang F, et al. Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration. Biomarkers 2009;14:321-5.
6. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005;38:698-710.
7. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study: III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med 2005;38: 711-8.
8. Wu XW, Lee CC, Muzny DM, Caskey CT. Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci U S A 1989;86:9412-6.
9. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 1981;78:6858-62.
10. Gruber J, Tang SY, Jenner AM, et al. Allantoin in human plasma, serum, and nasal-lining fluids as a biomarker of oxidative stress: avoiding artifacts and establishing real in vivo concentrations. Antioxid Redox Signal 2009;11:1767-76.
11. Carducci C, Birarelli M, Leuzzi V, et al. Guanidinoacetate and creatine plus creatinine assessment in physiologic fluids: an effective diagnostic tool for the biochemical diagnosis of arginine:glycine amidinotransferase and guanidinoacetate methyltransferase deficiencies. Clin Chem 2002;48:1772-8.
12. Taylor AW, Bruno RS, Frei B, Traber MG. Benefits of prolonged gradient separation for high-performance liquid chromatographytandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes. Anal Biochem 2006;350:41-51. (Pubitemid 43247625)
13. Haschke M, Zhang YL, Kahle C, et al. HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma. Clin Chem 2007;53:489-97.
14. Yan W, Byrd GD, Ogden MW. Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J Lipid Res 2007;48:1607-17.
15. Mross K, Maessen P, van der Vijgh WJ, et al. Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans. J Clin Oncol 1988;6:517-26.
16. Halliwell B, Lee CYJ. Using isoprostanes as biomarkers of oxidative stress. Some rarely-considered issues. Antioxid Redox Signal 2010 Mar 25 [Epub ahead of print].